vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in vTv Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +4 vs. Q2 2022
- Shares held
- 3.49M
- −156.1K (−4.3%) vs. Q2 2022
- Total value
- $3.38M
- +$634.1K (+23.1%) vs. Q2 2022
- New holders
- 5
- 5 more added
- Sold out
- 1
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 1,635,509 | $1.59M | 0.37% | 00.0% | Unchanged |
| Vanguard Group Inc | 938,970 | $911.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 290,000 | $281.0K | 0.00% | −76,618−20.9% | Reduced |
| State Street Corp | 134,745 | $131.0K | 0.00% | −71,400−34.6% | Reduced |
| Millennium Management LLC | 77,339 | $75.0K | 0.00% | −61,344−44.2% | Reduced |
| BlackRock Inc. | 55,420 | $54.0K | 0.00% | −287−0.5% | Reduced |
| Virtu Financial LLC | 43,954 | $43.0K | 0.00% | +5,395+14.0% | Added |
| Northern Trust Corp | 40,577 | $39.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 40,000 | $39.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 33,012 | $32.0K | 0.00% | −4,256−11.4% | Reduced |
| Morgan Stanley | 33,443 | $32.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 32,385 | $31.0K | 0.00% | +14,590+82.0% | Added |
| Simon Quick Advisors, LLC | 30,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 27,018 | $26.0K | 0.00% | +27,018 | New |
| Susquehanna International Group, LLP | 22,233 | $22.0K | 0.00% | +1,555+7.5% | Added |
| Veritable, L.P. | 20,905 | $20.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,760 | $13.0K | 0.00% | +13,760 | New |
| Strengthening Families & Communities, LLC | 7,142 | $6.00K | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 5,000 | $5.00K | 0.00% | +5,000 | New |
| Tower Research Capital LLC (TRC) | 4,577 | $4.00K | 0.00% | +4,577 | New |
| Advisor Group Holdings, Inc. | 2,060 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,211 | $2.00K | 0.00% | +1,009+83.9% | Added |
| Parallel Advisors, LLC | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 330 | $320 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 500 | $0 | 0.00% | −100−16.7% | Reduced |
| Royal Bank of Canada | 173 | $0 | 0.00% | +44+34.1% | Added |
| Northwest Investment Counselors, LLC | 500 | $0 | 0.00% | +500 | New |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −15,590−100.0% | Sold out |